MedPath

Clinical study of transplacental anti-arrythmic treatment for fetal tachyarrythmias

Not Applicable
Conditions
Fetal tachyarrythmia (Supraventricular tachycardia, Atrial flutter)
Registration Number
JPRN-UMIN000026378
Lead Sponsor
Gunma University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
5
Inclusion Criteria

Not provided

Exclusion Criteria

1 it is impossible to obtain informed consent due to the mental problem 2 the treatment causes serious risk for mother's health 3 Doctor judged inappropriate for the treatment

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
disappearance of fetal tachyarrythmias in more than half of 30min fetal echocardiogram and/or 40min cardiotocogram
Secondary Outcome Measures
NameTimeMethod
1 Intrauterine Fetal Death 2 Rate of preterm birth 3 Rate of cesarean section 4 Improvement of fetal heart rate and/or fetal hydrops 5 Neonatal arrythmias 6 CNS findings in neonate 7 Survival rate at 1 month 8 Tachyarrythmias at 1 month
© Copyright 2025. All Rights Reserved by MedPath